X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1216) 1216
Publication (206) 206
Book Review (12) 12
Book Chapter (10) 10
Dissertation (6) 6
Magazine Article (3) 3
Conference Proceeding (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (867) 867
female (838) 838
index medicus (817) 817
breast cancer (750) 750
oncology (610) 610
breast neoplasms - pathology (483) 483
basal-like (463) 463
breast neoplasms - metabolism (356) 356
middle aged (345) 345
prognosis (342) 342
breast neoplasms - genetics (336) 336
cancer (332) 332
immunohistochemistry (326) 326
basal-like subtype (319) 319
tumors (309) 309
adult (277) 277
expression (276) 276
pathology (265) 265
aged (253) 253
gene expression (239) 239
phenotype (231) 231
basal-like breast cancer (220) 220
research (202) 202
carcinoma (196) 196
chemotherapy (188) 188
metastasis (182) 182
cell biology (175) 175
genetic aspects (172) 172
survival (172) 172
animals (166) 166
analysis (165) 165
biomarkers, tumor - metabolism (163) 163
receptor, erbb-2 - metabolism (156) 156
gene expression regulation, neoplastic (154) 154
receptors, estrogen - metabolism (154) 154
cell line, tumor (152) 152
estrogen-receptor (150) 150
breast neoplasms - drug therapy (144) 144
aged, 80 and over (137) 137
gene expression profiling (137) 137
receptors, progesterone - metabolism (133) 133
estrogen (132) 132
triple-negative breast cancer (132) 132
breast neoplasms - mortality (122) 122
subtypes (122) 122
medicine & public health (120) 120
care and treatment (115) 115
carcinomas (114) 114
article (113) 113
basal-like phenotype (111) 111
mice (111) 111
biomarkers, tumor - analysis (110) 110
gene-expression (108) 108
breast neoplasms - classification (107) 107
brca1 (105) 105
epidermal growth factor (105) 105
epithelial-mesenchymal transition (103) 103
health aspects (100) 100
breast (95) 95
skin and connective tissue diseases (95) 95
development and progression (94) 94
medical prognosis (93) 93
progesterone (92) 92
stem cells (92) 92
mutation (91) 91
neoplasm staging (90) 90
biomarkers, tumor - genetics (86) 86
breast neoplasms - diagnosis (86) 86
proteins (82) 82
research article (82) 82
triple negative (81) 81
triple negative breast neoplasms - pathology (81) 81
biomarkers (76) 76
kaplan-meier estimate (76) 76
molecular portraits (76) 76
triple negative breast cancer (76) 76
antineoplastic agents - therapeutic use (74) 74
neoadjuvant chemotherapy (74) 74
cells (72) 72
cell proliferation (71) 71
medicine (71) 71
risk factors (71) 71
triple negative breast neoplasms - metabolism (71) 71
oligonucleotide array sequence analysis (70) 70
receptor, erbb-2 - genetics (69) 69
cancer therapies (68) 68
neoplasm invasiveness (68) 68
patterns (68) 68
genes (67) 67
breast neoplasms - chemistry (66) 66
gene (66) 66
markers (66) 66
triple negative breast neoplasms - genetics (66) 66
disease-free survival (65) 65
identification (64) 64
molecular subtypes (63) 63
oncology, experimental (63) 63
receptors, estrogen - analysis (63) 63
therapy (63) 63
breast carcinoma (62) 62
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1194) 1194
French (9) 9
Spanish (9) 9
Chinese (5) 5
Japanese (4) 4
Czech (3) 3
Polish (3) 3
Korean (2) 2
Portuguese (2) 2
Croatian (1) 1
Romanian (1) 1
Russian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 02/2008, Volume 14, Issue 4, pp. 1050 - 1058
Purpose: The β4 integrin has been implicated in functions associated with the genesis and progression of carcinomas based on data obtained from cell lines and... 
basal-like breast cancer | immunohistochemistry | integrin β4 | gene profiling | prognosis
Journal Article
Oncotarget, ISSN 1949-2553, 07/2018, Volume 9, Issue 53, pp. 30115 - 30127
Basal-like breast cancer (BLBC) is an aggressive breast cancer subtype with features similar to the basal cells surrounding the mammary ducts. Treatment of... 
Xenograft | HORMAD1 | Basal-like breast cancer | PARP inhibitor
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 06/2010, Volume 397, Issue 1, pp. 27 - 33
Evidence is mounting that the occurrence of the CD44 /CD24 cell population, which contains potential breast cancer (BC) stem cells, could explain BC clinical... 
Breast cancer | HER2 | Basal-like | Trastuzumab | Stem cells
Journal Article
NATURE REVIEWS CANCER, ISSN 1474-175X, 10/2007, Volume 7, Issue 10, pp. 791 - 799
Human breast cancers are heterogeneous, both in their pathology and in their molecular profiles. This suggests the hypothesis that breast cancers can initiate... 
SIDE POPULATION | ONCOLOGY | BASAL-LIKE SUBTYPE | GENE-EXPRESSION PATTERNS | ESTROGEN-RECEPTOR-ALPHA | SELF-RENEWAL | STEM/PROGENITOR CELLS | ACUTE MYELOID-LEUKEMIA | GLAND DEVELOPMENT | MAMMARY EPITHELIAL-CELLS | IN-VITRO PROPAGATION
Journal Article
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7403, pp. 395 - 399
Journal Article
by Koboldt, Daniel C and Fulton, Robert S and McLellan, Michael D and Schmidt, Heather and Kalicki-Veizer, Joelle and McMichael, Joshua F and Fulton, Lucinda L and Dooling, David J and Ding, Li and Mardis, Elaine R and Wilson, Richard K and Ally, Adrian and Balasundaram, Miruna and Butterfield, Yaron S. N and Carlsen, Rebecca and Carter, Candace and Chu, Andy and Chuah, Eric and Chun, Hye-Jung E and Coope, Robin J. N and Dhalla, Noreen and Guin, Ranabir and Hirst, Carrie and Hirst, Martin and Holt, Robert A and Lee, Darlene and Li, Haiyan I and Mayo, Michael and Moore, Richard A and Mungall, Andrew J and Pleasance, Erin and Robertson, A. Gordon and Schein, Jacqueline E and Shafiei, Arash and Sipahimalani, Payal and Slobodan, Jared R and Stoll, Dominik and Tam, Angela and Thiessen, Nina and Varhol, Richard J and Wye, Natasja and Zeng, Thomas and Zhao, Yongjun and Birol, Inanc and Jones, Steven J. M and Marra, Marco A and Cherniack, Andrew D and Saksena, Gordon and Onofrio, Robert C and Pho, Nam H and Carter, Scott L and Schumacher, Steven E and Tabak, Barbara and Hernandez, Bryan and Gentry, Jeff and Nguyen, Huy and Crenshaw, Andrew and Ardlie, Kristin and Beroukhim, Rameen and Winckler, Wendy and Getz, Gad and Gabriel, Stacey B and Meyerson, Matthew and Chin, Lynda and Kucherlapati, Raju and Hoadley, Katherine A and Auman, J. Todd and Fan, Cheng and Turman, Yidi J and Shi, Yan and Li, Ling and Topal, Michael D and He, Xiaping and Chao, Hann-Hsiang and Prat, Aleix and Silva, Grace O and Iglesia, Michael D and Zhao, Wei and Usary, Jerry and Berg, Jonathan S and Adams, Michael and Booker, Jessica and Wu, Junyuan and Gulabani, Anisha and Bodenheimer, Tom and Hoyle, Alan P and Simons, Janae V and Soloway, Matthew G and Mose, Lisle E and Jefferys, Stuart R and Balu, Saianand and Parker, Joel S and Hayes, D. Neil and Perou, Charles M and Malik, Simeen and Mahurkar, Swapna and Shen, Hui and Weisenberger, Daniel J and Triche Jr, Timothy and Lai, Phillip H and ... and Canc Genome Atlas Network and Cancer Genome Atlas Network and The Cancer Genome Atlas Network
Nature, ISSN 0028-0836, 10/2012, Volume 490, Issue 7418, pp. 61 - 70
We analysed primary breast cancers by genomic DNA copy number arrays, DNA methylation, exome sequencing, messenger RNA arrays, microRNA sequencing and... 
PATHWAYS | TARGET | BASAL-LIKE | SUPPRESSOR | PIK3CA GENE | SUBTYPES | MULTIDISCIPLINARY SCIENCES | HIGH-FREQUENCY | LUMINAL-B | CANCER | MUTATIONAL EVOLUTION | GATA3 Transcription Factor - genetics | Receptors, Estrogen - metabolism | Oligonucleotide Array Sequence Analysis | Genomics | Humans | Gene Expression Regulation, Neoplastic | Ovarian Neoplasms - pathology | Gene Expression Profiling | Breast Neoplasms - metabolism | Ovarian Neoplasms - genetics | DNA Methylation | DNA Mutational Analysis | Female | Genes, BRCA1 | Genes, Neoplasm - genetics | Breast Neoplasms - classification | RNA, Messenger - genetics | Retinoblastoma Protein - metabolism | DNA Copy Number Variations - genetics | Genes, p53 - genetics | Mutation - genetics | Genetic Heterogeneity | Genome, Human - genetics | Phosphatidylinositol 3-Kinases - genetics | Exome - genetics | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Genes, erbB-2 - genetics | Proteomics | Protein Array Analysis | RNA, Neoplasm - genetics | MAP Kinase Kinase Kinase 1 - genetics | MicroRNAs - genetics | Breast tumors | Gene mutations | Oncology, Experimental | Genetic aspects | Research | Identification and classification | Cancer | Proteins | DNA methylation | Genetics | Breast cancer | Mutation | Càncer de mama | Oncologia | Oncology | Gene expression | Expressió gènica | Genòmica
Journal Article
BREAST CANCER RESEARCH, ISSN 1465-542X, 2011, Volume 13, Issue 4
Introduction: The overexpression of human epidermal growth factor receptor (HER)-2 in 20% of human breast cancers and its association with aggressive growth... 
GROWTH-FACTOR RECEPTOR | BASAL-LIKE | APOPTOSIS | ONCOLOGY | SRC | IN-VIVO | THERAPEUTIC TARGET | FOCAL ADHESION KINASE | DRUG-RESISTANCE | INHIBITOR | TRASTUZUMAB RESISTANCE
Journal Article